Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Right now this is a SOLID buy. I would not be in a position to fill anything in, let's just say that all the ducks are aligned.
Biomoda may be skyrocketing soon...don't ask me.
You can't be serious Rain. Listen man, BMOD will come through...I know that. It will just take a little longer than previously thought. You seem to be right on your DD, but don't let that blind you from reality. BMOD's cause is commendable and once positive data kicks in, the stock should rise significantly because the confidence that this could work with other cancers will be there. People will say..Hey, if this is happening with the lung cancer most likely it will happen with the cervical and other cancers as well so phase 2 data is super key. But in the meantime people will trade the stock and that is reality. I am also long, but as a hedge I also trade some. Now, to think that I hurt the stock price by having a contrarian theory or briefly addressing possible setbacks is just irrational. For every half, there is another half. That creates balance.
So I guess you are saying that my posts, which are not utterly and unsubstantiated negative but rather of a more observing and reasonable nature, have the power to bring the stock down. Gosh I must be so powerful..So I guess that I have more power than Rain, whom posts 20 times more than I do. So basically, if do not post for the next 5 days..then the stock should go up. The stock went down because o the dilution. Period
Double the volume? Mostly sells. Something fishy...certainly. Most likely scenario: Dilution news.
All I am hoping is that this is just "normal" and not result of some news leak where JC needs more time or something. If I would have JC next to me..I would biittch slap him..
Rain, I have NEVER admitted I utilize this board to MANIPULATE the prices. Please re-post anything from me stating that. This is a FORUM, where information is exchanged. According to your theory I, by negatively posting or not too favorable comments, am manipulating the price to go down. Well, arguing the very same theory, it would be fair to say that you, by positively posting,a re trying to manipulate the price to go up. Isn't that the same? Secondly, I have not posted any misleading information either. Just like yourself, all I have done is interpret what has been said by BMOD or its officers. Interpretation are just that, and investors may have different perceptions. I predicted the stock would reach 0.16 within 2 weeks of its high..and it happened. You said that it wouldn't and obviously the one who was right was me.
Rain could u be a gentleman and admit I was right?
My orders got filled in the 0.17's..waiting for my 0.16's to happen now. I guess I was right..
I also hold a large position. I will increase it though, once this reaches 0.16-17.5 which should happen pretty soon. Good time to average down before the rise in PPS by August 30 per stated by J.C.
That would be assuming "every" BMOD stockholder knows IHUB. As far as I am concerned, there s only 5 cats in this board: Pureloyd, Shinola, KEI, YOU and me...and rarely someone else kicks in. Kind of funny actually..lol..We gotta make our house nicer guys so we attract more people...
I'm sorry Rain, but I don't think IHUB is that powerful to cause the PPS to either rise or decline. If that premise were to hold true BMOD's stock would be $15 given all the "positive" comments you make right?
I am happy as well. I already bought 60% of the 240K shares I had sold between 0.23 & 0.24 . I am buying the remaining 40% between 0.16 and 0.175 this week. I think it is pretty decent.
Why are you always belittling my posts Rain? This is what I actually think, if this would be a Nasdaq stock with a lot of volume perhaps not, but it isn't. Only 300K shares trade hands on a daily basis, except when news hit in which case it may go to 500K shares, other than that is not like all of their outstanding shares are exchanged. But it is fair to say that out of all the shares traded TODAY, 95% were sales. When I mentioned a week ago that this stock would be trading in the teens you called me crazy and said that I would never see this below 0.20..I guess you were wrong. You never admit you are wrong. Anybody who has been doing this a long time knows that this stock will go down to 0.15 or 0.16..news are not a block away...if anything it will be a happy medium between the announced 60 days..that is still 30 days from today...so please don't be so narrow minded to other posters. We respect your opinion, but you should reciprocate..this is a forum, and ALL opinions should be taken into consideration.
Massive sell off..Only 11,200 shares bought and over 160K sold @ 0.19..
What do you see in the charts?
Sure..but this will definitely touch 0.16 before it hits 0.75...a lot of downward pressure from the charts
Seems like there has been some covering. Short interest went down from 350K plus shares down to 60K
http://www.shortsqueeze.com/?symbol=bmod&submit=Short+Quote%99
Pure, I am guessing that the data will be analyzed by the very same individual who delivered the 100% accuracy during the phase I. Correct me if I am wrong. What could we possibly see PPS wise if the data comes out as 100% accurate this time around as well? Not 90, not 95 but 100%.
How do you think the pps rise will play out? My guess is that there should be a "leak" and, if positive, MM's will try to an initial scare, to pick up shares very cheap and then slowly rise until news hit and then, of course, the steep rise. Thoughts?
Seems like the board is taking a rest...odd..
I was in & out of this stock last year. Now i am back. Can someone fill me on what is going on exactly and what is the PPS expectations in the short term? It would be greatly appreciated. GLTA
I thought about it too Pure. Difficult to figure. May be we should send an email or call and ask if dilution is in the nearly horizon. Perhaps we can get something.
Did you ask about China?
Those are some very interesting predictions. But I would assume that further dilution would take place also.
Exactly what I thought..lol
Found it..not a public company but with a CE mark in place.
http://www.medicalacoustics.com/Home/About
Which is the company that develops the flute? I would assume that such company would stand to capitalize and generate revenue stream from BMOD's approval. Is it a public company?
Best strategy is to have 50% sitting and the other 50% trading so at least you are even.
Whatever it is, I think the smart money will know first and we should watch for a quick run prior to data.
Hopefully the PR comes this month. It is plausible. But we'll see I guess.
In the meantime I think the stock will still swing between 0.16 & 0.20
Certainly. The key will be to figure which publication I guess.
This is the response I got from BMOD last night:
Aaron told me that you called today and I am sorry that events kept me from returning the call immediately. As we announced in late June, we have completed enrollment and patient sample collection for both cohorts, including high risk participants and those who were diagnosed with lung cancer but had not begun treatment. This is a significant milestone. The study team currently is analyzing data in accordance with the study protocol. The integrity and thoroughness of this clinical study is of paramount importance to those of us at Biomoda. As such, we continue to work diligently to complete the study and issue its results.
The LifeTech analysis quoting timelines and expectations is an independent analysis conducted without direction nor influence by Biomoda. We do not endorse their forecasts nor their analysis. As I said on the phone several weeks ago, the results of the Phase II study will be published in a peer review journal determined by Dr. Bauer, the Principal Investigator and primary author of the paper detailing the clinical study. Biomoda anticipates issuing a media release with a summary of the results prior to publication of the paper. We expect this media release to be the first public announcement explaining results of the Phase II clinical trial. We will make sure you are on our email list for distribution of the media release.
Dr. Bauer and the clinical team will determine the publication in which the full paper will be published. We expect they will balance the necessity of thorough peer review and prestige of a publication with the desire to publish results quickly. In all cases, the clinical team will expertly document and analyze data for the most insightful understanding and explanation of the assay. We view the work being completed now as an essential step towards commercialization. I cannot provide you with a timeline for publication. Mr. Cousins, in his recent interview, suggested his estimate for issuance of top-line data. I will reiterate that we have completed a major milestone with the completion of enrollment and sample collection from patients. We are diligently completing data analysis. We will issue results when most appropriate to provide a strong basis for Phase III trials.
The information provided to our shareholders and the public is the best available information at the time of its release. We have at no time misled our shareholders nor the public regarding the progress and the operations at Biomoda. In hindsight, changing events and opportunities have shifted expected timelines. When these changes occur, we have notified the public and shareholders accordingly. We believe that in every case our decisions have been best for the Company and shareholder investment.
I appreciate your interest and support for Biomoda. I hope you will continue to contact me with questions, comments or concerns.
Sincerely,
Maria Zannes
Corporation Secretary and Director
Biomoda
On Wed, Jul 7, 2010 at 4:13 PM, Dante Grasso <dg@portaterraholdings.com> wrote:
I have written to you in the past regarding your technology and its development. One of the areas that remain a grey area is the consistent misleading information being furnished to the stockholders. The most recent: an updated research by Lifetech Capital stating that data from the Phase II trials is expected in July, 2010 while in an interview hosted by Corporate Profile John Cousins clearly mentions that data completion could take 2 months. Seems like your timing and delay is a never ending pattern which is further deteriorating the credibility of Biomoda.
As a large stockholder, I would like to point out that BMOD is not only a life sciences company but also a business and financial entity accountable to all of its stakeholders.
Why would it take two months to evaluate the data? If apparently part of it had already been analyzed. Please clarify.
Sincerely,
Rain, i really appreciate all the DD and effort that you have put into this. It really helps making the decision easier. I repeat, I own shares in BMOD and I believe in their product but that does not mean I could stop trading it. Very well said by Skiptovel, as I can relate to him and his thoughts.
Rain, hopefully you are right. Hopefully JC is utilizing the reverse strategy where he has been late in all of his announcements and now by announcing two months he delivers the fast ball this month making him look good all around. That is certainly a possibility and it would be great, but then again..
Got it Pure.
This is business buddy. Nothing personal. The MM's do this all day long. That doesn't mean we can't be smart investors right? You know very well that the statement JC threw yesterday was very surprising to all of us. Nobody expected to hear the 2 month mark again. Don't blind yourself.
Rain, unless you are someone that has had lung cancer or have been directly affected by the disease in one way or the other, I am sure you are here to make money. This is the stock market, people play it to make money. The cause can be noble, but isn't the whole biotech that way in the first place?
I called today and spoke to this guy that filters the info to Maria Zannes. I was fairly aggressive in my tone and demanded to speak to JC or her asap.